CINCOR PHARMA INC - COM (CINC)

CUSIP: 17240Y109

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM
Total 13F shares
37,281,794
Share change
+5,652,369
Total reported value
$1,223,330,069
Put/Call ratio
410%
Price per share
$32.82
Number of holders
84
Value change
+$201,032,576
Number of buys
69
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 17240Y109?
CUSIP 17240Y109 identifies CINC - CINCOR PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CINCOR PHARMA INC - COM (CINC) as of Q3 2022

As of 30 Sep 2022, CINCOR PHARMA INC - COM (CINC) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,281,794 shares. The largest 10 holders included Sofinnova Investments, Inc., 5AM Venture Management, LLC, GENERAL ATLANTIC, L.P., PERCEPTIVE ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., venBio Partners LLC, RTW INVESTMENTS, LP, BlackRock Inc., BVF INC/IL, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 84 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.